Tumor derived carbohydrate binding protein
US6423314B1 · kind B1 · utility
15Cited by
0References
12Claims
0Family size
Inventor
Key dates
| Filing date | Dec 28, 2000 |
| Grant date | Jul 23, 2002 |
| Priority date | — |
| Expiry date | Dec 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/18
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced. The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cell as well as therapeutic methodologies and materials.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.